Dr Thomas A Vanmeter, MD | |
334 S Patterson Ave, Ste 105, Santa Barbara, CA 93111-2475 | |
(805) 964-1514 | |
(805) 964-0861 |
Full Name | Dr Thomas A Vanmeter |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 52 Years |
Location | 334 S Patterson Ave, Santa Barbara, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205832813 | NPI | - | NPPES |
00A253700 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | A25370 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Thomas A Vanmeter, MD 334 S Patterson Ave, Ste 105, Santa Barbara, CA 93111-2475 Ph: (805) 964-1514 | Dr Thomas A Vanmeter, MD 334 S Patterson Ave, Ste 105, Santa Barbara, CA 93111-2475 Ph: (805) 964-1514 |
News Archive
Men receiving radiation therapy to combat early-stage prostate cancer are still able to achieve an erection and face a low rate of incontinence one year following treatment, according to a new study published in the July 15, 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
Sens. Richard Burr (R-N.C.), Lamar Alexander (R-Tenn.) and Tom Coburn (R-Okla.) and Reps. Devin Nunes (R-Calif.) and Paul Ryan (R-Wis.) on Wednesday introduced the Patients' Choice Act (S 1099, HR 2520), a counter proposal to Democratic health care reform plans that would create state-based health insurance exchanges and provide U.S. residents tax credits to subsidize coverage premiums, Roll Call reports (Drucker [1], Roll Call, 5/20).
Age, seriousness of impairment, and the severity of other medical conditions are important indicators of how long an individual might survive after an Alzheimer's disease diagnosis, Eric B. Larson, M.D., M.P.H. and colleagues report in the April 6 Annals of Internal Medicine. Study authors include Linda Teri, Ph.D., recipient of an Alzheimer's Association $1 million Pioneer research grant.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
› Verified 6 days ago
Dr. Rebecca Dawn Miller, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 334 S Patterson Ave, Ste 105, Santa Barbara, CA 93111 Phone: 805-964-1514 Fax: 805-964-0861 | |
George Keith Llewellyn, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1722 State St, Ste 103, Santa Barbara, CA 93101 Phone: 805-884-4900 Fax: 805-884-4900 | |
Meredith A Perrin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 334 S Patterson Ave Ste 105, Santa Barbara, CA 93111 Phone: 805-964-1514 Fax: 805-964-0861 | |
Dr. Mark E Burnett, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2323 Oak Park Ln Ste 202, Santa Barbara, CA 93105 Phone: 805-892-8111 | |
Dr. Peter Ford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-681-1761 Fax: 805-681-1768 | |
Dr. Roy C. Grekin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2320 Bath Street, Suite 205, Santa Barbara, CA 93105 Phone: 805-569-1164 Fax: 805-569-1094 |